CSS LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,700
Closed -$2.67M 1117
2022
Q3
$2.67M Buy
33,700
+15,900
+89% +$1.34M 0.13% 179
2022
Q2
$1.32M Buy
+17,800
New +$1.34M 0.05% 374
2022
Q1
Sell
-35,000
Closed -$3.92M 1338
2021
Q4
$3.92M Buy
35,000
+30,000
+600% +$3.62M 0.14% 130
2021
Q3
$629K Sell
5,000
-10,000
-67% -$1.29M 0.03% 563
2021
Q2
$2.03M Sell
15,000
-15,000
-50% -$1.97M 0.08% 251
2021
Q1
$4.07M Buy
30,000
+20,000
+200% +$2.99M 0.17% 107
2020
Q4
$1.41M Sell
10,000
-77,800
-89% -$9.96M 0.05% 258
2020
Q3
$9.78M Buy
87,800
+55,700
+174% +$6.24M 0.46% 38
2020
Q2
$3.59M Buy
+32,100
New +$3.16M 0.2% 113
2020
Q1
Sell
-25,000
Closed -$2.38M 773
2019
Q4
$2.38M Buy
+25,000
New +$2.16M 0.13% 138

Other funds holding XBI

CSS LLC's XBI Position: Q2 2021 in Review

CSS LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2021, closing a stake of 4,500 shares — an estimated $592K sold.

CSS LLC first reported a position in XBI in Q3 2020 and held it in 2 quarters. The position peaked at $2.67M in Q3 2020. 663 funds tracked by Wall St. Rank hold XBI as of Q2 2021.

  • CSS LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2021 after selling out during the quarter.
  • CSS LLC sold 4,500 State Street SPDR S&P Biotech ETF shares in Q2 2021, an estimated $592K.
  • CSS LLC first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and held it in 2 quarters.
  • CSS LLC's State Street SPDR S&P Biotech ETF position peaked at $2.67M in Q3 2020.
  • 663 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.